国: イギリス
言語: 英語
ソース: MHRA (Medicines & Healthcare Products Regulatory Agency)
Tetracaine hydrochloride
Bausch & Lomb UK Ltd
S01HA03
Tetracaine hydrochloride
10mg/1ml
Eye drops
Ocular
No Controlled Drug Status
Valid as a prescribable product
BNF: 11070000; GTIN: 5027519000203
Graphics&Packing Technology Section ICN POLFA RZESZÓW S.A. ULOTKA PIL Nazwa produktu Product Name MINIMS TETRACAINE HYDROCHLORIDE 0,5% AND 1% W/V DRP SOL Kolor nadruku Colours Black Kraj Country (ISO) UNITED KINGDOM (UK), IRELAND (IE) Nr wykrojnika Spec No 5338 Opracowane przez Designed by Kod Wytwórcy Manufacturer code 76863 Nr korekty Proof No 6 Data Date 09.04.2015 Kod farmaceutyczny Pharmacode - Kod wersji Valeant version code P9UKIE01 Inny kod Other code 76863 (DATA MATRIX) Rozmiar czcionki Font size MINIMUM 8 PT Wymiar ulotki PIL size 160 X 240 MM Krój czcionki Font used Frutiger Neue LT W1G Condensed FRUTIGER NEUE LT W1G CONDENSED BOLD Gramatura papieru Paper weight - G/M 2 Komentarze Comments (Reason for the change) MAH TRANSFER FROM CHAUVIN PHARMACEUTICALS LTD UK TO B+L UK LTD PMR_ICN-14-0811-A PACKING SITE: LABORATOIRE CHAUVIN, AUBENAS, FRANCE Akceptacja Techniczna Technical Approval Akceptacja Działu ds. Rejestracji Regulatory Affairs Dept. Approval MINIMS® TETRACAINE HYDROCHLORIDE 0.5% W/V MINIMS® TETRACAINE HYDROCHLORIDE 1% W/V EYE DROPS, SOLUTION TETRACAINE HYDROCHLORIDE IN THIS LEAFLET: 1. What Minims® Tetracaine Hydrochloride eye drops are and what they are used for 2. Before you use your eye drops 3. How to use your eye drops 4. Possible side effects 5. How to store your eye drops 6. Further information 1. WHAT MINIMS® TETRACAINE HYDROCHLORIDE EYE DROPS ARE AND WHAT ARE THEY USED FOR Minims® Tetracaine Hydrochloride contains a local anaesthetic. It is used to numb the eye temporarily. Your doctor or eye specialist may use it to examine or treat your eye without it being painful. This medicine should be avoided in premature babies. 2. BEFORE YOU USE YOUR EYE DROPS DO NOT USE THESE DROPS IF • if you are allergic to the active substance (tetracaine) or any of the other ingredients (refer to the end of this leaflet). • if you are allergic to other similar types of local anaesthetic. • if you are taking medicines used to treat bacterial infection or diabetes called “sulphonamides”. 完全なドキュメントを読む
OBJECT 1 MINIMS TETRACAINE HYDROCHLORIDE 1.0% W/V, EYE DROPS SOLUTION Summary of Product Characteristics Updated 29-Jul-2015 | Bausch & Lomb U.K Limited 1. Name of the medicinal product Minims Tetracaine Hydrochloride 1% w/v Eye Drops, Solution 2. Qualitative and quantitative composition Single-use, clear, colourless, sterile eye drops tetracaine hydrochloride Ph.Eur. 1% w/v solution. 3. Pharmaceutical form Single-use, sterile eye drops. 4. Clinical particulars 4.1 Therapeutic indications Ocular anaesthetic for topical instillation into the conjunctival sac. 4.2 Posology and method of administration Adults and children One drop or as required. Each Minims unit should be discarded after use. 4.3 Contraindications Not to be used in patients with a known hypersensitivity to the product. Tetracaine is hydrolysed in the body to p-amino-benzoic acid and should not therefore be used in patients being treated with sulphonamides. In view of the immaturity of the enzyme system which metabolises the ester type local anaesthetics in premature babies, tetracaine should be avoided in these patients. 4.4 Special warnings and precautions for use The anaesthetised eye should be protected from dust and bacterial contamination. The cornea may be damaged by prolonged application of anaesthetic eye drops. Systemic absorption may be reduced by compressing the lacrimal sac at the medial canthus for a minute during and following the instillation of the drops. (This blocks the passage of the drops via the naso lacrimal duct to the wide absorptive area of the nasal and pharyngeal mucosa. It is especially advisable in children.) 4.5 Interaction with other medicinal products and other forms of interaction Tetracaine should not be used in patients being treated with sulphonamides (see 4.3 above) 4.6 Pregnancy and lactation Safety for use in pregnancy and lactation has not been established, therefore, use only when considered essential by the physician. 4.7 Effects on ability to drive and use machines May cause transient blurring of vision on 完全なドキュメントを読む